NO20083461L - Genekspresjonsmarkorer for kolorektal cancer-prognose - Google Patents
Genekspresjonsmarkorer for kolorektal cancer-prognoseInfo
- Publication number
- NO20083461L NO20083461L NO20083461A NO20083461A NO20083461L NO 20083461 L NO20083461 L NO 20083461L NO 20083461 A NO20083461 A NO 20083461A NO 20083461 A NO20083461 A NO 20083461A NO 20083461 L NO20083461 L NO 20083461L
- Authority
- NO
- Norway
- Prior art keywords
- colorectal cancer
- gene expression
- cancer prognosis
- expression markers
- expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Fremgangsmåte for å forutse klinisk resultat i et individ som er diagnostisert med kolorektal kreft som omfatter å vise uttrykket av et eller flere av prediktive RNA-transkript eller deres uttrykksprodukter i en biologisk prøve av kreftceller som er tilveiebrakt fra individet.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75839206P | 2006-01-11 | 2006-01-11 | |
US80027706P | 2006-05-12 | 2006-05-12 | |
US81007706P | 2006-05-31 | 2006-05-31 | |
PCT/US2007/000995 WO2007082099A2 (en) | 2006-01-11 | 2007-01-11 | Gene expression markers for colorectal cancer prognosis |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20083461L true NO20083461L (no) | 2008-10-10 |
Family
ID=38257063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20083461A NO20083461L (no) | 2006-01-11 | 2008-08-08 | Genekspresjonsmarkorer for kolorektal cancer-prognose |
Country Status (15)
Country | Link |
---|---|
US (10) | US7695913B2 (no) |
EP (9) | EP1974058B1 (no) |
JP (7) | JP5297202B2 (no) |
KR (1) | KR20090003178A (no) |
AU (1) | AU2007204826B2 (no) |
BR (1) | BRPI0706511A2 (no) |
CA (1) | CA2636984A1 (no) |
DK (1) | DK1974058T3 (no) |
ES (1) | ES2491222T3 (no) |
HK (1) | HK1120089A1 (no) |
IL (1) | IL192794A (no) |
MX (1) | MX2008008973A (no) |
NO (1) | NO20083461L (no) |
NZ (7) | NZ593227A (no) |
WO (1) | WO2007082099A2 (no) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1570080A4 (en) | 2002-11-15 | 2006-03-01 | Genomic Health Inc | GENE EXPRESSION PROFILING OF EGFR-POSITIVE CANCER DISEASE |
CA2563074C (en) | 2004-04-09 | 2014-05-20 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
EP1974058B1 (en) * | 2006-01-11 | 2014-06-11 | Genomic Health, Inc. | Gene expression markers for colorectal cancer prognosis |
CN103424541B (zh) | 2006-05-18 | 2018-01-30 | 分子压型学会股份有限公司 | 确定针对病状的个性化医疗介入的系统和方法 |
US8768629B2 (en) | 2009-02-11 | 2014-07-01 | Caris Mpi, Inc. | Molecular profiling of tumors |
US20090076734A1 (en) | 2007-03-22 | 2009-03-19 | Torres-Roca Javier F | Gene Signature for the Prediction of Radiation Therapy Response |
US20080234946A1 (en) * | 2007-03-22 | 2008-09-25 | University Of South Florida | Predictive radiosensitivity network model |
DK2140269T3 (da) | 2007-03-27 | 2013-12-16 | Immunovia Ab | Proteinsignatur/markører til at detektere adenocarcinom |
US20090123920A1 (en) * | 2007-11-08 | 2009-05-14 | Maher Albitar | Jak2 mutations |
ES2332167B1 (es) | 2007-12-04 | 2010-10-25 | Universidad Autonoma De Madrid | Empleo de trefoil factor-family 3 (tff3) en el pronostico de sujetos diagnosticados con cancer colorectal. |
WO2009123634A1 (en) * | 2008-04-02 | 2009-10-08 | Regents Of The University Of California | Systems and methods for predicting response of biological samples |
US8067178B2 (en) | 2008-03-14 | 2011-11-29 | Genomic Health, Inc. | Gene expression markers for prediction of patient response to chemotherapy |
NZ589143A (en) | 2008-05-14 | 2012-02-24 | Genomic Health Inc | Colorectal cancer response prediction based on AREG EREG DUSP6 and SLC26A3 expression levels |
US20100029748A1 (en) * | 2008-08-04 | 2010-02-04 | Sloan-Kettering Institute For Cancer Research | Metastasis Promoting Genes and Proteins |
US10359425B2 (en) * | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
US20100221752A2 (en) * | 2008-10-06 | 2010-09-02 | Somalogic, Inc. | Ovarian Cancer Biomarkers and Uses Thereof |
US20110257034A1 (en) * | 2008-10-10 | 2011-10-20 | Cornell University | Methods for identifying genes which predict disease outcome for patients with colon cancer |
US20120041274A1 (en) | 2010-01-07 | 2012-02-16 | Myriad Genetics, Incorporated | Cancer biomarkers |
US8765383B2 (en) * | 2009-04-07 | 2014-07-01 | Genomic Health, Inc. | Methods of predicting cancer risk using gene expression in premalignant tissue |
SG175832A1 (en) * | 2009-05-01 | 2011-12-29 | Genomic Health Inc | Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy |
TWI513465B (zh) * | 2009-06-25 | 2015-12-21 | Regeneron Pharma | 以dll4拮抗劑與化學治療劑治療癌症之方法 |
EP2591126B1 (en) | 2010-07-07 | 2020-12-30 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
SG10201508656VA (en) | 2010-07-09 | 2015-11-27 | Somalogic Inc | Lung cancer biomarkers and uses thereof |
EP3556870B9 (en) | 2010-07-27 | 2022-09-28 | Genomic Health, Inc. | Method for using gene expression to determine prognosis of prostate cancer |
AU2011289284B2 (en) | 2010-08-13 | 2015-04-09 | Somalogic Operating Co., Inc. | Pancreatic cancer biomarkers and uses thereof |
WO2012030840A2 (en) | 2010-08-30 | 2012-03-08 | Myriad Genetics, Inc. | Gene signatures for cancer diagnosis and prognosis |
SG188397A1 (en) | 2010-09-15 | 2013-04-30 | Almac Diagnostics Ltd | Molecular diagnostic test for cancer |
AU2012209074A1 (en) | 2011-01-25 | 2013-07-11 | Almac Diagnostics Limited | Colon cancer gene expression signatures and methods of use |
AU2012330817A1 (en) | 2011-11-04 | 2014-05-22 | Oslo Universitetssykehus Hf | Methods and biomarkers for analysis of colorectal cancer |
US20140314662A1 (en) | 2011-11-28 | 2014-10-23 | Institucio Catalana De Recerca / Estudis Avancats | Methods and kits for the prognosis of colorectal cancer |
US10519506B2 (en) | 2011-12-22 | 2019-12-31 | Baylor Research Institute | Identification of metastasis-specific miRNA and hypomethylation signatures in human colorectal cancer |
JP2015503923A (ja) * | 2012-01-09 | 2015-02-05 | オスロ ウニヴェルスィテーツスィーケフース ハーエフOslo Universitetssykehus Hf | 結腸直腸癌の解析のための方法およびバイオマーカー |
MX351626B (es) | 2012-01-31 | 2017-10-23 | Genomic Health Inc | Algoritmo de perfil de expresion genica y prueba para determinar la prognosis de cancer de prostata. |
WO2013150167A2 (es) | 2012-04-03 | 2013-10-10 | Servicio Andaluz De Salud | Modelo de expresión de microarn como indicador de supervivencia en pacientes de cancer colorrectal metastásico |
WO2014077915A1 (en) * | 2012-11-14 | 2014-05-22 | Mayo Foundation For Medical Education And Research | Methods and materials for identifying malignant skin lesions |
EP4190918A1 (en) | 2012-11-16 | 2023-06-07 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
ES2475366B1 (es) * | 2012-12-10 | 2015-05-05 | Fundación Imdea Alimentación | Métodos y kits para el pronóstico del cáncer colorrectal |
WO2014159791A1 (en) | 2013-03-14 | 2014-10-02 | Abbott Molecular Inc. | Materials and methods for assessment of colorectal adenoma |
AR096507A1 (es) * | 2013-05-30 | 2016-01-13 | Fundació Institució Catalana De Recerca I Estudis Avançats | Métodos y kits para el pronóstico del cáncer colorrectal |
US10185809B1 (en) * | 2013-10-15 | 2019-01-22 | Iqvia Inc. | Patient projection methodology |
GB201319878D0 (en) * | 2013-11-11 | 2013-12-25 | Immunovia Ab | Method, Array and use thereof |
US20170176441A1 (en) * | 2014-03-28 | 2017-06-22 | Applied Proteomics, Inc. | Protein biomarker profiles for detecting colorectal tumors |
CA2947624A1 (en) | 2014-05-13 | 2015-11-19 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
WO2016025717A1 (en) | 2014-08-14 | 2016-02-18 | Mayo Foundation For Medical Education And Research | Methods and materials for identifying metastatic malignant skin lesions and treating skin cancer |
JP7065609B6 (ja) | 2014-10-24 | 2022-06-06 | コーニンクレッカ フィリップス エヌ ヴェ | 複数の細胞シグナル伝達経路活性を用いる治療応答の医学的予後及び予測 |
JP7065610B6 (ja) | 2014-10-24 | 2022-06-06 | コーニンクレッカ フィリップス エヌ ヴェ | 複数の細胞シグナル伝達経路活性を用いる治療応答の医学的予後及び予測 |
WO2016062891A1 (en) | 2014-10-24 | 2016-04-28 | Koninklijke Philips N.V. | ASSESSMENT OF TGF-β CELLULAR SIGNALING PATHWAY ACTIVITY USING MATHEMATICAL MODELLING OF TARGET GENE EXPRESSION |
WO2016084130A1 (ja) | 2014-11-25 | 2016-06-02 | 三菱電機株式会社 | 空圧式アクチュエータ |
US20180148789A1 (en) * | 2014-12-01 | 2018-05-31 | University Of Southern California | Methods for treating and assessing tumor invasion and metastasis |
EP3073268A1 (en) * | 2015-03-27 | 2016-09-28 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Biomarker panel for diagnosing cancer |
JP2018517892A (ja) | 2015-04-10 | 2018-07-05 | アプライド プロテオミクス,インク. | 結腸直腸癌と進行腺腫を検知するためのタンパク質バイオマーカーパネル |
EP3316159A4 (en) * | 2015-06-25 | 2019-08-14 | Advanced Telecommunications Research Institute International | PREDICTIVE EQUIPMENT BASED ON A SYSTEM ASSOCIATED WITH SEVERAL INSTITUTIONS AND PREDICTION PROGRAM |
ES2861400T3 (es) | 2015-08-14 | 2021-10-06 | Koninklijke Philips Nv | Evaluación de la actividad de la ruta de señalización celular de NFkB usando modelos matemáticos de la expresión de genes diana |
WO2017170803A1 (ja) | 2016-03-29 | 2017-10-05 | 株式会社国際電気通信基礎技術研究所 | 医薬組成物又は食品組成物、及び有効成分の体内での効果の評価方法 |
MX2018013815A (es) | 2016-05-10 | 2019-07-04 | Mayo Found Medical Education & Res | Metodos y materiales para estadificar y tratar cancer de piel. |
WO2018165532A1 (en) | 2017-03-10 | 2018-09-13 | Baylor Research Institute | Methods for diagnosing and treating gastric cancer using mirna expression |
WO2018224731A1 (en) * | 2017-06-05 | 2018-12-13 | Ls Cancerdiag Oy | A method for determining whether a subject is at risk to develop cancer and tools related thereto |
EP3461915A1 (en) | 2017-10-02 | 2019-04-03 | Koninklijke Philips N.V. | Assessment of jak-stat1/2 cellular signaling pathway activity using mathematical modelling of target gene expression |
EP3502279A1 (en) | 2017-12-20 | 2019-06-26 | Koninklijke Philips N.V. | Assessment of mapk-ap 1 cellular signaling pathway activity using mathematical modelling of target gene expression |
JP7027179B2 (ja) * | 2018-01-24 | 2022-03-01 | キヤノン株式会社 | 給送回転体、シート給送装置及び画像形成装置 |
EP3762493A4 (en) | 2018-03-08 | 2021-11-24 | University of Notre Dame du Lac | SYSTEMS AND METHODS FOR EVALUATING THE MOLECULAR SUBTYPE AND RELIABILITY RISK OF COLON CANCER AND DETERMINING AND ADMINISTERING TREATMENT PROTOCOLS BASED ON THEM |
KR102007450B1 (ko) * | 2018-05-31 | 2019-08-05 | 한국과학기술연구원 | 대장암 치료제 발굴을 위한 신규 표적 치료 작용점의 스크리닝 방법 및 이를 이용하여 선별한 대장암 치료 예후 바이오마커 |
EP3886809A4 (en) | 2018-11-28 | 2022-03-30 | Genascence Corporation | METHODS AND COMPOSITIONS FOR THE TREATMENT OF OSTEOARTHRITIS |
WO2020123699A1 (en) * | 2018-12-11 | 2020-06-18 | The Trustees Of Columbia University In The City Of New York | Compounds and compositions that cause mycn and/or cmyc degradation and methods of use thereof |
CN110257518B (zh) * | 2019-07-01 | 2022-08-02 | 复旦大学附属中山医院 | 一种用于预测转移性结直肠癌转化治疗疗效的基因集 |
KR102263984B1 (ko) * | 2020-02-21 | 2021-06-11 | 재단법인 아산사회복지재단 | 직장암 환자에서 수술-전 화학방사선치료의 반응을 예측하기 위한 분석방법 |
KR102535150B1 (ko) * | 2020-04-14 | 2023-05-23 | 주식회사 베르티스 | 암의 예후 예측용 조성물 |
WO2021222220A2 (en) * | 2020-04-29 | 2021-11-04 | Freenome Holdings, Inc. | Rna markers and methods for identifying colon cell proliferative disorders |
GB202010970D0 (en) | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
CN112322730B (zh) * | 2020-10-16 | 2023-04-18 | 上海市第一人民医院 | 预测肿瘤耐药、复发的标志物kifc1及其抑制剂和应用 |
EP4026918A1 (en) | 2021-01-12 | 2022-07-13 | Koninklijke Philips N.V. | Prediction of an outcome of a colorectal cancer subject |
CN113667673B (zh) * | 2021-07-15 | 2024-02-06 | 武汉血液中心 | 一种类孟买血型FUT1 236delG等位基因及其检测方法和应用 |
KR20230059642A (ko) * | 2021-10-26 | 2023-05-03 | 사회복지법인 삼성생명공익재단 | miRNA를 포함하는 대장암의 치료 및 전이 억제용 조성물 및 이의 용도 |
WO2024035653A1 (en) * | 2022-08-06 | 2024-02-15 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Predictive biomarker in avastin in colon cancer |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020172987A1 (en) * | 1998-02-12 | 2002-11-21 | Terstappen Leon W.M.M. | Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
WO1999064627A2 (en) | 1998-06-06 | 1999-12-16 | Genostic Pharma Limited | Probes used for genetic profiling |
CA2330929A1 (en) * | 1998-06-06 | 1999-12-16 | Genostic Pharma Limited | Probes used for genetic profiling |
WO2000024940A1 (en) | 1998-10-28 | 2000-05-04 | Vysis, Inc. | Cellular arrays and methods of detecting and using genetic disorder markers |
EP0999016B1 (en) * | 1998-11-06 | 2001-07-11 | Temco S. R. L. | Cutter for cross cutting of webs |
US6692916B2 (en) * | 1999-06-28 | 2004-02-17 | Source Precision Medicine, Inc. | Systems and methods for characterizing a biological condition or agent using precision gene expression profiles |
US6960439B2 (en) * | 1999-06-28 | 2005-11-01 | Source Precision Medicine, Inc. | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
AU7721500A (en) * | 1999-09-29 | 2001-04-30 | Human Genome Sciences, Inc. | Colon and colon cancer associated polynucleotides and polypeptides |
AU2088801A (en) * | 1999-12-10 | 2001-06-18 | Dana-Farber Cancer Institute, Inc. | Metastasis genes and uses thereof |
US7029677B2 (en) * | 2000-01-25 | 2006-04-18 | Nuvelo, Inc. | Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells |
WO2001077164A2 (en) | 2000-04-06 | 2001-10-18 | Epigenomics Ag | Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis |
WO2005000087A2 (en) | 2003-06-03 | 2005-01-06 | Chiron Corporation | Gene products differentially expressed in cancerous colon cells and their methods of use ii |
AU2001280982A1 (en) | 2000-08-03 | 2002-02-18 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
US20030166064A1 (en) * | 2000-08-03 | 2003-09-04 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
WO2002012280A2 (en) | 2000-08-03 | 2002-02-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
US20030077568A1 (en) * | 2000-09-15 | 2003-04-24 | Gish Kurt C. | Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
EP1339872A2 (en) | 2000-09-19 | 2003-09-03 | Whitehead Institute For Biomedical Research | Genetic markers for tumors |
AU2002246519A1 (en) * | 2000-11-20 | 2002-08-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
US20030087818A1 (en) * | 2001-02-02 | 2003-05-08 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
AU2002311903A1 (en) * | 2001-05-09 | 2002-11-18 | University Hospitals Of Cleveland | Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto |
US20030148314A1 (en) * | 2001-08-01 | 2003-08-07 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of colon cancer |
US7622260B2 (en) * | 2001-09-05 | 2009-11-24 | The Brigham And Women's Hospital, Inc. | Diagnostic and prognostic tests |
KR20040064275A (ko) * | 2001-11-09 | 2004-07-16 | 소스 프리시전 메디슨, 인코포레이티드 | 유전자 발현 프로파일을 이용한 질병의 동정, 모니터링,치료 및 생물학적 상태의 확인 |
WO2003041562A2 (en) * | 2001-11-14 | 2003-05-22 | Whitehead Institute For Biomedical Research | Molecular cancer diagnosis using tumor gene expression signature |
US20030148410A1 (en) * | 2001-12-10 | 2003-08-07 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of colon cancer |
EP1534739A4 (en) * | 2002-01-18 | 2006-05-31 | Bristol Myers Squibb Co | IDENTIFICATION OF POLYNUCLEOTIDES AND POLYPEPTIDES FOR PREDICTING THE ACTIVITY OF COMPOUNDS THAT INTERACT WITH TYROSINE KINASE PROTEINS AND / OR TYROSINE KINASE PROTEIN PATHWAYS |
US7955800B2 (en) * | 2002-06-25 | 2011-06-07 | Advpharma Inc. | Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients |
US20040053317A1 (en) * | 2002-09-10 | 2004-03-18 | Sidney Kimmel Cancer Center | Gene segregation and biological sample classification methods |
AU2003304203A1 (en) | 2002-10-29 | 2005-01-04 | Pharmacia Corporation | Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same |
EP1597391B1 (en) * | 2003-02-20 | 2008-10-29 | Genomic Health, Inc. | Use of intronic rna to measure gene expression |
WO2005008213A2 (en) | 2003-07-10 | 2005-01-27 | Genomic Health, Inc. | Expression profile algorithm and test for cancer prognosis |
US20050014165A1 (en) * | 2003-07-18 | 2005-01-20 | California Pacific Medical Center | Biomarker panel for colorectal cancer |
WO2005015236A2 (en) | 2003-07-18 | 2005-02-17 | Roche Diagnostics Gmbh | A method for predicting the progression of adenocarcinoma |
WO2005012875A2 (en) * | 2003-07-29 | 2005-02-10 | Bristol-Myers Squibb Company | Biomarkers of cyclin-dependent kinase modulation |
EP1522594A3 (en) | 2003-10-06 | 2005-06-22 | Bayer HealthCare AG | Methods and kits for investigating cancer |
WO2005076005A2 (en) | 2004-01-30 | 2005-08-18 | Medizinische Universität Wien | A method for classifying a tumor cell sample based upon differential expression of at least two genes |
US20060195266A1 (en) * | 2005-02-25 | 2006-08-31 | Yeatman Timothy J | Methods for predicting cancer outcome and gene signatures for use therein |
WO2005100593A1 (en) | 2004-04-16 | 2005-10-27 | Monash University | A method for monitoring the progress of cancer |
CA2574447A1 (en) | 2004-07-15 | 2006-01-26 | University Of Utah Research Foundation | Housekeeping genes and methods for identifying the same |
US20060183893A1 (en) | 2005-01-25 | 2006-08-17 | North Don A | Nucleic acids for apoptosis of cancer cells |
WO2006110581A2 (en) | 2005-04-07 | 2006-10-19 | Novartis Vaccines And Diagnostics Inc. | Cancer-related genes |
CA2612021A1 (en) * | 2005-06-13 | 2006-12-28 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
US20090299640A1 (en) | 2005-11-23 | 2009-12-03 | University Of Utah Research Foundation | Methods and Compositions Involving Intrinsic Genes |
WO2007070621A2 (en) | 2005-12-13 | 2007-06-21 | Children's Medical Center Corporation | Prognosis indicators for solid human tumors |
NZ544432A (en) | 2005-12-23 | 2009-07-31 | Pacific Edge Biotechnology Ltd | Prognosis prediction for colorectal cancer using a prognositc signature comprising markers ME2 and FAS |
EP1974058B1 (en) | 2006-01-11 | 2014-06-11 | Genomic Health, Inc. | Gene expression markers for colorectal cancer prognosis |
US20100009905A1 (en) | 2006-03-24 | 2010-01-14 | Macina Roberto A | Compositions and Methods for Detection, Prognosis and Treatment of Colon Cancer |
CA2680591A1 (en) * | 2007-03-15 | 2008-09-25 | Genomic Health, Inc. | Gene expression markers for prediction of patient response to chemotherapy |
US8067178B2 (en) * | 2008-03-14 | 2011-11-29 | Genomic Health, Inc. | Gene expression markers for prediction of patient response to chemotherapy |
US8765383B2 (en) * | 2009-04-07 | 2014-07-01 | Genomic Health, Inc. | Methods of predicting cancer risk using gene expression in premalignant tissue |
SG175832A1 (en) * | 2009-05-01 | 2011-12-29 | Genomic Health Inc | Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy |
-
2007
- 2007-01-11 EP EP07717900.0A patent/EP1974058B1/en active Active
- 2007-01-11 EP EP10194722A patent/EP2400036A1/en not_active Withdrawn
- 2007-01-11 KR KR1020087019544A patent/KR20090003178A/ko not_active Application Discontinuation
- 2007-01-11 EP EP10194719.0A patent/EP2412823B1/en not_active Not-in-force
- 2007-01-11 NZ NZ593227A patent/NZ593227A/xx unknown
- 2007-01-11 EP EP10194714.1A patent/EP2412821B1/en not_active Not-in-force
- 2007-01-11 EP EP10194715A patent/EP2407553A1/en not_active Withdrawn
- 2007-01-11 NZ NZ593225A patent/NZ593225A/xx unknown
- 2007-01-11 NZ NZ593229A patent/NZ593229A/xx unknown
- 2007-01-11 EP EP10194717A patent/EP2412822A1/en not_active Withdrawn
- 2007-01-11 BR BRPI0706511-6A patent/BRPI0706511A2/pt not_active IP Right Cessation
- 2007-01-11 NZ NZ593224A patent/NZ593224A/xx unknown
- 2007-01-11 EP EP10194713A patent/EP2412820A1/en not_active Withdrawn
- 2007-01-11 DK DK07717900.0T patent/DK1974058T3/da active
- 2007-01-11 ES ES07717900.0T patent/ES2491222T3/es active Active
- 2007-01-11 JP JP2008550454A patent/JP5297202B2/ja active Active
- 2007-01-11 EP EP10177406.5A patent/EP2377950B1/en not_active Not-in-force
- 2007-01-11 NZ NZ593228A patent/NZ593228A/xx unknown
- 2007-01-11 MX MX2008008973A patent/MX2008008973A/es active IP Right Grant
- 2007-01-11 US US11/653,102 patent/US7695913B2/en active Active
- 2007-01-11 AU AU2007204826A patent/AU2007204826B2/en active Active
- 2007-01-11 WO PCT/US2007/000995 patent/WO2007082099A2/en active Application Filing
- 2007-01-11 CA CA002636984A patent/CA2636984A1/en not_active Abandoned
- 2007-01-11 EP EP10194720.8A patent/EP2412824B1/en not_active Not-in-force
- 2007-01-11 NZ NZ569788A patent/NZ569788A/en unknown
- 2007-01-11 NZ NZ593226A patent/NZ593226A/xx unknown
-
2008
- 2008-07-13 IL IL192794A patent/IL192794A/en active IP Right Grant
- 2008-08-08 NO NO20083461A patent/NO20083461L/no not_active Application Discontinuation
-
2009
- 2009-01-15 HK HK09100394.3A patent/HK1120089A1/xx not_active IP Right Cessation
-
2010
- 2010-01-29 US US12/696,934 patent/US8153378B2/en active Active
- 2010-10-25 US US12/911,532 patent/US8029995B2/en active Active
- 2010-10-25 US US12/911,519 patent/US8273537B2/en active Active
- 2010-10-25 US US12/911,544 patent/US8153380B2/en active Active
- 2010-10-25 US US12/911,551 patent/US8026060B2/en active Active
- 2010-10-25 US US12/911,526 patent/US8153379B2/en active Active
-
2011
- 2011-01-19 US US13/009,733 patent/US8198024B2/en active Active
-
2012
- 2012-03-06 US US13/413,338 patent/US8367345B2/en active Active
- 2012-12-13 JP JP2012272400A patent/JP5486664B2/ja active Active
- 2012-12-28 US US13/729,462 patent/US20130102492A1/en not_active Abandoned
-
2013
- 2013-06-13 JP JP2013124949A patent/JP5486718B2/ja active Active
- 2013-06-13 JP JP2013124952A patent/JP2013215201A/ja active Pending
- 2013-06-13 JP JP2013124951A patent/JP5486720B2/ja active Active
- 2013-06-13 JP JP2013124950A patent/JP5486719B2/ja active Active
- 2013-06-13 JP JP2013124948A patent/JP5486717B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20083461L (no) | Genekspresjonsmarkorer for kolorektal cancer-prognose | |
Hong et al. | DNA methylation-based age prediction from saliva: High age predictability by combination of 7 CpG markers | |
WO2008115419A3 (en) | Gene expression markers for prediction of patient response to chemotherapy | |
MX2011011571A (es) | Algoritmo de perfil de expresion genica y prueba para probabilidad de recidiva de cancer colorrectal y respuesta a la quimioterapia. | |
WO2009113779A3 (ko) | Snp 어레이를 이용한 염색체, 유전자, 또는 특정 뉴클레오티드 서열의 카피 수 측정방법 | |
BRPI0816393A2 (pt) | Método para determinar o número de cópias relativo de uma sequência de polinucleotídeo alvo em um genoma de um indivíduo | |
MX2018011725A (es) | Metodo para emplear expresion genica para determinar pronostico de cancer de prostata. | |
WO2011056489A3 (en) | Diagnostic methods for determining prognosis of non-small cell lung cancer | |
WO2008030845A8 (en) | Methods of predicting distant metastasis of lymph node-negative primary breast cancer using biological pathway gene expression analysis | |
ATE526333T1 (de) | Reagentien zum nachweis von hypochloriger säure | |
BR112012030813A2 (pt) | "métodos e kits para detecção in situ de sequências de nucleotídeo" | |
WO2009055823A3 (en) | Method to predict responsiveness of breast cancer to polyaminetype chemotherapy | |
BRPI0821698A2 (pt) | Método para manipular, isolar, detectar ou amplificar um ácido nucleico alvo em uma amostra por hibridização com um conjugado de oligonucleotídeo-oligocátion. | |
DK2021794T3 (da) | Anvendelse af protein S100A 12 som en markør for colorektal cancer | |
Langevin et al. | Novel DNA methylation targets in oral rinse samples predict survival of patients with oral squamous cell carcinoma | |
EA201291228A1 (ru) | Биомаркер для детекции высокогорной адаптации и высокогорного отека легких | |
MX2013008252A (es) | Firma de pronostico para la recurrencia de cancer colorrectal. | |
WO2012106711A3 (en) | A method for detecting chromosome structure and gene expression simultaneously in single cells | |
WO2011008814A3 (en) | Multiplexed measurement of exogenous and endogenous dna | |
BR112013004044A2 (pt) | composições e métodos para quantificação de uma sequência de ácido nucleico em uma amostra. | |
WO2008122447A3 (en) | Dna methylation assay for the diagnosis or prognosis of medical conditions | |
WO2010077288A3 (en) | Methods for identifying differences in alternative splicing between two rna samples | |
WO2009086000A3 (en) | Biomarkers for trichogenicity | |
WO2010030167A3 (en) | Method of detection and diagnosis of oral and nasopharyngeal cancers | |
BRPI0507392A (pt) | método e kit para determinar a possibilidade de metástase de cáncer em um indivìduo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |